dc.contributor.author
Arismendi, Ebymar
dc.contributor.author
Riva, Eva
dc.contributor.author
Agustí García-Navarro, Àlvar
dc.contributor.author
Ríos, José
dc.contributor.author
Barreiro, Esther
dc.contributor.author
Vidal i Cortada, Josep
dc.contributor.author
Rodríguez-Roisin, Robert
dc.date.issued
2017-05-22T10:59:23Z
dc.date.issued
2017-05-22T10:59:23Z
dc.date.issued
2014-09-19
dc.date.issued
2017-05-22T10:59:24Z
dc.identifier
https://hdl.handle.net/2445/111387
dc.description.abstract
INTRODUCTION: Obesity is associated with low-grade systemic inflammation. The 'inflammome' is a network layout of the inflammatory pattern. The systemic inflammome of obesity has not been described as yet. We hypothesized that it can be significantly worsened by smoking and other comorbidities frequently associated with obesity, and ameliorated by bariatric surgery (BS). Besides, whether or not these changes are mirrored in the lungs is unknown, but obesity is often associated with pulmonary inflammation and bronchial hyperresponsiveness. OBJECTIVES: We sought to: (1) describe the systemic inflammome of morbid obesity; (2) investigate the effects of sex, smoking, sleep apnea syndrome, metabolic syndrome and BS upon this systemic inflammome; and, (3) determine their interplay with pulmonary inflammation. METHODS: We studied 129 morbidly obese patients (96 females; age 46 ± 12 years; body mass index [BMI], 46 ± 6 kg/m2) before and one year after BS, and 20 healthy, never-smokers, (43 ± 7 years), with normal BMI and spirometry. RESULTS: Before BS, compared with controls, all obese subjects displayed a strong and coordinated (inflammome) systemic inflammatory response (adiponectin, C-reactive protein, interleukin (IL)-8, IL-10, leptin, soluble tumor necrosis factor-receptor 1(sTNF-R1), and 8-isoprostane). This inflammome was not modified by sex, smoking, or coexistence of obstructive sleep apnea and/or metabolic syndrome. By contrast, it was significantly ameliorated, albeit not completely abolished, after BS. Finally, obese subjects had evidence of pulmonary inflammation (exhaled condensate) that also decreased after BS. CONCLUSIONS: The systemic inflammome of morbid obesity is independent of sex, smoking status and/or comorbidities, it is significantly reduced by BS and mirrored in the lungs.
dc.format
application/pdf
dc.format
application/pdf
dc.publisher
Public Library of Science (PLoS)
dc.relation
Reproducció del document publicat a: https://doi.org/10.1371/journal.pone.0107859
dc.relation
PLoS One, 2014, vol. 9, num. 9, p. e107859
dc.relation
https://doi.org/10.1371/journal.pone.0107859
dc.rights
cc-by (c) Arismendi, Ebymar et al., 2014
dc.rights
http://creativecommons.org/licenses/by/3.0/es
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Medicina)
dc.subject
Obesitat mòrbida
dc.subject
Marcadors bioquímics
dc.subject
Cirurgia de l'obesitat
dc.subject
Morbid obesity
dc.subject
Biochemical markers
dc.subject
Obesity surgery
dc.title
The systemic inflammome of severe obesity before and after bariatric surgery
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion